Patent Attorney Joins UAMS BioVentures

By David Robinson

Fasel facilitates licensing and license transfers of UAMS-based discoveries. UAMS technologies and intellectual property are licensed to startup companies sponsored through UAMS BioVentures or may be acquired by outside companies, typically medical and pharmaceutical companies.

The BioVentures Technology Licensing Office also supports UAMS researchers in identifying, disclosing and patenting their inventions.

Fasel most recently was a patent attorney/licensing assistant at the University of Missouri Office of Technology Management in Columbia, Mo. His experience enables him to assist BioVentures’ outside legal counsel on patent prosecution and evaluation, legal opinions and legal action.

UAMS BioVentures began operation in 1997. Today, 25 UAMS startup companies are providing 532 jobs with a $26.5 million annual payroll.

UAMS is a Level 1 trauma center and the state’s only comprehensive academic health center, with colleges of Medicine, Nursing, Pharmacy, Health Related Professions and Public Health; a graduate school; a 540,000-square-foot hospital; a statewide network of regional centers; and six institutes: the Winthrop P. Rockefeller Cancer Institute, the Jackson T. Stephens Spine & Neurosciences Institute, the Myeloma Institute for Research and Therapy, the Harvey & Bernice Jones Eye Institute, the Psychiatric Research Institute and the Donald W. Reynolds Institute on Aging. UAMS has 2,836 students and 761 medical residents. It is the state’s largest public employer with more than 10,000 employees, including nearly 1,150 physicians who provide medical care to patients at UAMS, Arkansas Children’s Hospital, the VA Medical Center and UAMS’ Area Health Education Centers throughout the state. Visit or